Cash

Trending Midterms Elections Politics Sports Culture Crypto Commodities Climate Economics Mentions Finance Tech & Science

Predict Live100 AccountSocial

MARKETS PERPS LIVE100

Product

Kalshi Pro Perpetual Futures Markets Incentive program Institutions API & developers

Company

About Kalshi Research Blog Careers Policy Center Brand Kit

Help

Help Center FAQ Fee schedule Trading hours Regulatory Trust Center

© 2026 Kalshi Inc. · All rights reserved

Privacy Data Terms of Service Trading Prohibitions FAQ for Finance Professionals

Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.

Eli Lilly and (LLY) earnings | Kalshi

Eli Lilly and

LLY

ReportsOct 29, 2026 · before open

Fiscal periodNot stated

Market cap$1.17T

Consensus EPS$5.38 · 3 estimates

Year-ago EPS$7.02

Expected change-23.4%

Quarterly markets

What will Eli Lilly say during their next earnings call?

Foundayo
87%
Alzheimer
85%
LillyDirect
80%
Jaypirca
79%
Inluriyo
78%
Vial
70%
AI / Artificial Intelligence
51%
Headwind
45%
ESMO
45%
Omvoh
35%
Tariff
32%
Tailwind
27%

5 more words trade on this call